Danvers, MA, United States
Danvers, MA, United States
SEARCH FILTERS
Time filter
Source Type

DANVERS, Mass.--(BUSINESS WIRE)--Samsung will introduce the new HS50 and HS60 ultrasound systems designed for busy clinical practices offering a compact design with a simplified workflow, excellent imaging performance, and advanced measurement and volume imaging capabilities that enable users to effectively manage routine exams. The systems received FDA clearance earlier this spring and will be unveiled at the American College of Obstetricians and Gynecologists annual meeting in San Diego from May 6-9, 2017. “With the introduction of the HS50 and HS60, Samsung is able to bring the exceptional image quality and penetration that our high-end customers have come to expect and rely on to a wider audience,” said Phil Sullivan, President and CEO for Samsung NeuroLogica. “With its smaller footprint and affordability, it will allow more clinicians to provide their patients the very best of care.” The HS50 and HS60 feature hybrid beamformer technology that works in conjunction with Samsung’s advanced Digital Signal Processing to provide clear, detailed images that help clinicians confidently diagnose and care for their patients. Advanced 3D/4D technologies provide additional diagnostic views to help support clinical decision making and treatment planning, and workflow enhancing and time-saving tools allow the clinician to focus more on their patients instead of the system. The well-rounded capabilities of the HS50 and HS60 make them a great fit for many different practice types, including Obstetrics and Gynecology, General Imaging and MSK. About Samsung NeuroLogica Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd, develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungMedicalSolution.com.


Global Spectral Computed tomography (CT) Market Information by types (Cardiac Imaging, Neutral Imaging, Clinical images others) by applications (Cardiovascular, Neurovascular, Spinal others) by end users (Hospitals, diagnostic centers) - Forecast to 2027Pune, India - April 25, 2017 /MarketersMedia/ — Market Scenario: Computed tomography (CT) has enjoyed in a position of unmistakable quality in medicinal imaging since its creation in the past decades. The methodology gives a more complete picture of the body than X-rays, its predecessor, taking images at a few distinct angles to construct a cross area, including bone and tissue. The inconvenience is that it can be hard to recognize one object from another in the white palette, especially with regards to smaller injuries or metal artifacts inside the body. Segments On the Basis of Types • Cardiac Imaging • Neutral Imaging • Clinical images On the basis of Application • Cardiovascular • Neurovascular • Spinal On the Basis of End Users • Diagnostic Centers • Hospitals Key Players • General Electric Company, • Hitachi medical corporation, • NeuroLogica Corp, • Neusoft Medical Systems, • Koninklijke Philips N.V., • Siemens Healthcare GmbH, • Shenzhen Anke High-tech Co., Ltd Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1026 Study Objectives of Spectral Computed tomography (CT) Market: • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Global Spectral Computed tomography (CT) Market • To provide insights about factors affecting the market growth • To Analyze the Global Spectral Computed Tomography (CT) Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and RoW • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by type, by application, by end users and sub-segments. • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Spectral Computed tomography (CT) Market Regional Analysis of Spectral Computed tomography (CT) Market: Globally North America is the largest market for Spectral Computed tomography (CT). The North American market for Spectral Computed tomography (CT) is expected to grow at high CAGR by the end of the forecasted period. Europe is the second-largest market for Spectral Computed tomography (CT) which is expected to grow at good CAGR. Browse Report @ https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market Brief Table of Content 1. Report Prologue 2. Introduction 2.1 Definition 2.2 Scope of the Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 2.3 Market Structure 2.4. Market Segmentation 3. Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.5 Forecast Model 4. Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Mega Trends 4.5 Macroeconomic Indicators 5. Market Factor Analysis 5.1 Value Chain Analysis 5.2 Porters Five Forces 5.3 Demand & supply: gap analysis 5.4 Pricing Analysis 5.5 Investment Opportunity Analysis 5.6 Merger and Acquisition Landscape 5.7 UP-Coming trends in IOT market 5.7.1 Market trends 5.7.2 Technological trends 5.7.3 Insurance & Regulations 5.7.4 Others 6. Global Spectral Computed Tomography Market by Types Continue…….. The report for Global Spectral Computed Tomography (CT) Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions Related Report Global Big Data in Healthcare Market Research Report, by Hardware (Routers, VPNs), by Software (EHR, Practice Management), by Analytical service type (Descriptive, Predictive, Prescriptive) by region (Europe, Americas, APAC & MEA) - Forecast to 2027 https://www.marketresearchfuture.com/reports/big-data-healthcare-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Info:Name: Akash AnandEmail: akash.anand@marketresearchfuture.comOrganization: Market Research FutureAddress: Office No. 528, Amanora Chambers Magarpatta Road, HadapsarPhone: +1 646 845 9312Source URL: http://marketersmedia.com/spectral-computed-tomography-ct-market-growth-opportunities-key-driving-factors-market-scenario-and-forecast-to-2027/189920For more information, please visit https://www.marketresearchfuture.com/reports/spectral-computed-tomography-marketSource: MarketersMediaRelease ID: 189920


News Article | July 24, 2017
Site: www.businesswire.com

DANVERS, Mass.--(BUSINESS WIRE)--Samsung’s BodyTom®, the world’s first portable, full-body, 32-slice CT (computed tomography) scanner, just got even better. The BodyTom Elite® is the newly upgraded BodyTom, which received FDA 510(k) clearance on June 14, 2017. Incorporating a fresh new visual design, upgraded software, hardware and workstation the BodyTom Elite will make its mark as the go-to premium advanced full-body mobile CT scanner. “We reengineered the BodyTom Elite so that it more seamlessly integrates into any OR, Neurosurgery, Radiation Oncology or Radiology Suite, and provides a more accurate, sharper image,” said CEO Philip Sullivan. In the world of advanced imaging, millimeters can be the difference when it comes to delivering an accurate diagnosis or treatment. With this in mind, our team of R&D engineers spent the past year designing and improving hardware solutions, such as: Significant improvements were also made to the workstation, including: “We run a very busy department and depend on our equipment to deliver the highest quality results possible with ease to the patient. The Samsung BodyTom® Elite does all the above and more allowing for safe, precise, and effective treatment. The state-of-the-art BodyTom Elite features advanced technology including intuitive ergonomics, whisper-quiet portability, and exceptional image quality only to improve our department’s efficiency and patient comfort,” stated Michael Woodruff, Director of Medical Imaging at John Muir Health. BodyTom Elite is XR-29 (MITA Smart Dose) compliant and as such includes four key features of CT equipment that enable optimization or management of radiation dose delivery – dose structured reporting, CT dose check, AEC and pediatric and adult reference protocols. The BodyTom Elite remains a self-shielded, multi-departmental imaging solution capable of transforming any room in the hospital into an advanced imaging suite. The system can accommodate patients of all sizes, and its combination of rapid scan time, flexible settings, and immediate image viewing makes the BodyTom Elite a valuable tool to any facility needing versatile real-time portable imaging. “From top to bottom, the BodyTom Elite is designed to empower our customers to capture the absolute best imaging information from their patients,” said Philip Sullivan. About Samsung NeuroLogica Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.


DANVERS, Mass.--(BUSINESS WIRE)--Samsung, a leader in medical imaging technology, is enhancing its commitment to serve more Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) across the country with its suite of innovative medical imaging solutions that deliver the best patient outcomes and experiences at the lowest cost. “Samsung has a great history of delivering innovative products that have the highest customer value. That philosophy of value excellence is well aligned with a corporate account organization’s goal of ensuring maximum value to their members,” said Philip Sullivan, Samsung, NeuroLogica Division, President and CEO. Samsung’s suite of innovative imaging products delivers the sharpest picture through an intuitive design that enhances the patient and clinician experience, all at an affordable price point. To get this message out to the market, Sullivan recently promoted David Legg, an executive with more than 25 years of experience working with IDNs and GPOs, to Vice President, Corporate Accounts. “David’s promotion is a sign of our commitment to serve and grow our corporate accounts base,” said Sullivan. “He brings a wealth of experience to the role and will provide healthcare systems with innovative, cost-effective imaging solutions for their hospitals and patients.” Legg heads up a growing team focused on expanding Samsung’s corporate accounts business, which has already made great accomplishments, signing large-volume contracts with some of the largest commercial and government customers in the country. “Our philosophy of delivering innovative products that offer the absolute best patient and clinician experience at the lowest possible cost aligns perfectly with the goals of GPOs and IDNs, who are trying to do the same thing,” said Legg. “Samsung’s well-established brand is already associated with innovation, and our healthcare products are no different.” About Samsung NeuroLogica Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.


A high resolution single photon emission computed tomography (SPECT) imaging system comprising:


Patent
NeuroLogica | Date: 2014-01-06

A composite skull pin comprising:


Patent
NeuroLogica | Date: 2015-04-17

An anatomical imaging system comprising; a CT machine and a transport mechanism mounted to the base of the CT machine, wherein the transport mechanism comprises a fine movement mechanism for moving the CT machine precisely, relative to the patient, during scanning. An anatomical imaging system comprising: a CT machine; and a transport mechanism mounted to the base of the CT machine, wherein the transport mechanism comprises: An imaging system comprising: a scanner; and a transport mechanism mounted to the base of the scanner, wherein the transport mechanism comprises: A method for scanning a patient comprising: providing an anatomical imaging system, the system comprising; transporting the CT machine to the patient, across room distances, using the gross movement mechanism; and scanning the patient while moving the CT machine precisely, relative to the patient, with the fine movement mechanism. A method for scanning a patient, comprising: moving a CT machine across room distances to the patient; and scanning the patient while moving the CT machine precisely relative to the patient during scanning. A method for scanning an object, comprising: moving a scanner across room distances to the the object; and scanning the object while moving the scanner precisely relative to the object during scanning.


A method for providing CT fluoroscopy of an internal procedure site during a medical procedure so as to visualize patient anatomy and a high-contrast medical element during the procedure without subjecting the patient to unacceptable quantities of X-ray radiation, comprising: (1) taking a standard intensity CT scan of the internal procedure site; (2) taking a reduced intensity CT scan of the procedure site while the high-contrast medical element is inserted into the procedure site; (3) extracting the high-contrast medical element portion of the reduced intensity CT scan from the reduced intensity CT scan; (4) merging the high-contrast medical element portion of the reduced intensity CT scan extracted in Step 3 with the standard intensity CT scan of the procedure site taken in Step 1 so as to provide a composite CT scan; (5) displaying the composite CT scan; and (6) returning to either Step 1 or Step 2.


An X-ray tube mount for mounting an X-ray tube assembly to the rotating disk assembly of a CT imaging system, said X-ray tube mount comprising:

Loading NeuroLogica collaborators
Loading NeuroLogica collaborators